147 results on '"Pick, Marjorie"'
Search Results
2. OA-34 Feasibility of a novel academic anti-BCMA chimeric antigen receptor T-cell (CART) (HBI0101) for the treatment of relapsed and refractory AL amyloidosis
3. P-026 Safety and efficacy of a locally produced novel anti-BCMA chimeric antigen receptor T-cell (CART) (HBI0101) for the treatment of relapsed and refractory multiple myeloma
4. Amyloidogenic light chains impair plasma cell survival
5. Development and manufacturing of novel locally produced anti-BCMA CART cells for the treatment of relapsed/refractory multiple myeloma: phase I clinical results
6. Feasibility of a Novel Academic BCMA-CART (HBI0101) for the Treatment of Relapsed and Refractory AL Amyloidosis
7. CD24 Is a Prognostic Marker for Multiple Myeloma Progression and Survival
8. Understanding the Bioactivity and Prognostic Implication of Commonly Used Surface Antigens in Multiple Myeloma
9. Learning from Patients: The Interplay between Clinical and Laboratory Research in AL Amyloidosis
10. Serum Hevylite ® assay in the differential diagnosis of patients with high suspicion of AL Amyloidosis
11. Generation of Megakaryocytes and Platelets from Human Pluripotent Stem Cells
12. Oncogenic Transformation of Normal Enterocytes by Overexpression of Cyclin D1
13. TRIM13 (RFP2) downregulation decreases tumour cell growth in multiple myeloma through inhibition of NF Kappa B pathway and proteasome activity
14. Induced Pluripotent Stem Cells: Their Role in Modeling Disease and Regenerative Medicine
15. ARP, A Peptide Derived from the Stress-Associated Acetylcholinesterase Variant, Has Hematopoietic Growth Promoting Activities
16. Stress-induced cholinergic signaling promotes inflammation-associated thrombopoiesis
17. Stem cell factor (SCF) synergizes with megakaryocyte colony stimulating activity in post-irradiated aplastic plasma in stimulating human megakaryocytopoiesis
18. Immunological evaluation of patients with hematological malignancies receiving ambulatory cytokine-mediated immunotherapy with recombinant human interferon-α2a and interleukin-2
19. From Brain to Blood: Alternative Splicing Evidence for the Cholinergic Basis of Mammalian Stress Responses
20. Serum Hevylite® assay in the differential diagnosis of patients with high suspicion of AL Amyloidosis.
21. Placing the newborn on the maternal abdomen after delivery increases the volume and CD34+ cell content in the umbilical cord blood collected: An old maneuver with new applications
22. The role of CD24 in multiple myeloma tumorigenicity and effects of the microenvironment on its expression
23. Expansion of megakaryocyte progenitors from human umbilical cord blood using a new two-step separation procedure
24. In-vivo platelet activation correlates with red cell anionic phospholipid exposure in patients with beta-thalassaemia major
25. Daratumumab resistance is frequent in advanced-stage multiple myeloma patients irrespective of CD38 expression and is related to dismal prognosis
26. Feasibility of a Novel Academic Anti-BCMA Chimeric Antigen Receptor T-Cell (CART) (HBI0101) for the Treatment of Relapsed and Refractory AL Amyloidosis
27. Safety and Efficacy of a Locally Produced Novel Anti-BCMA Chimeric Antigen Receptor T-Cell (CART) (HBI0101) for the Treatment of Relapsed and Refractory Multiple Myeloma
28. The role of CD24 in multiple myeloma tumorigenicity and the effect of the microenvironment on CD24 expression
29. The Role of CD24 in Multiple Myeloma Tumorigenicity and the Effect of the Microenvironment on CD24 Expression
30. Generation of Megakaryocytes and Platelets from Human Pluripotent Stem Cells.
31. Directed Differentiation of Embryonic Stem Cells
32. Endurance Exercise Diverts the Balance between Th17 Cells and Regulatory T Cells
33. Generation of Megakaryocytic Progenitors from Human Embryonic Stem Cells in a Feeder- and Serum-Free Medium
34. Reprogramming of the MHC‐I and Its Regulation by NFκB in Human‐Induced Pluripotent Stem Cells
35. The Role of the IAP Livin in Megakaryocytes Differentiation and Thrombopoiesis
36. Activation of the Alternative NFκB Pathway Improves Disease Symptoms in a Model of Sjogren's Syndrome
37. Clone- and Gene-Specific Aberrations of Parental Imprinting in Human Induced Pluripotent Stem Cells
38. Enforced Expression of Mixl1 During Mouse ES Cell Differentiation Suppresses Hematopoietic Mesoderm and Promotes Endoderm Formation
39. Differentiation of Human Embryonic Stem Cells in Serum-Free Medium Reveals Distinct Roles for Bone Morphogenetic Protein 4, Vascular Endothelial Growth Factor, Stem Cell Factor, and Fibroblast Growth Factor 2 in Hematopoiesis
40. Quantitative flow cytometry of ZAP-70 levels in chronic lymphocytic leukemia using molecules of equivalent soluble fluorochrome
41. Hydrolytic and Nonenzymatic Functions of Acetylcholinesterase Comodulate Hemopoietic Stress Responses
42. Cholinergic Stress Responses Facilitate the Molecular Mechanisms Underlying Granulocytosis.
43. Quantitation of Zap-70 Expression in B-CLLCells Employing a Novel Flow Cytometry Analysis Method.
44. Blood‐cell‐specific acetylcholinesterase splice variations under changing stimuli
45. Celecoxib But Not Rofecoxib Inhibits the Growth of Transformed Cellsin Vitro
46. The stress-associated acetylcholinesterase variant AChE-R is expressed in human CD34+ hematopoietic progenitors and its C-terminal peptide ARP promotes their proliferation
47. Ex vivo expansion of megakaryocyte progenitors from cryopreserved umbilical cord blood
48. Celecoxib inhibits the growth of transformed but not normal cells while rofecoxib does not have any inhibition properties
49. Down regulation of bak expression in normal enterocytes by anti-sense construct results in malignant transformation
50. In‐vivo platelet activation correlates with red cell anionic phospholipid exposure in patients with β‐thalassaemia major
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.